Skip to content

Acupuncture for Chemical Therapy Induced Nausea and Vomiting: a Cross-over Trail

Acupuncture for Chemical Therapy Induced Nausea and Vomiting: a Cross-over Trail

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02127255
Acronym
ACTIN
Enrollment
39
Registered
2014-04-30
Start date
2014-04-30
Completion date
2015-12-31
Last updated
2016-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy-induced Nausea and Vomiting

Keywords

chemotherapy, nausea, vomiting, cancer

Brief summary

This is a randomized, controlled cross-over trial. The hypothesis of this study is that the differences in manual acupuncture manipulation can impact clinical effect though the acupuncturists follow the same needling regimen. In this study, acupuncturist 1 (clinical experience \>15 years) and acupuncturist 2 (\<5 years) will give treatments to cancer patients receiving cisplatin chemotherapy (n=36) for at least two continuous cycles, once per day, 5 days per cycle. Acupuncturist 1 determines all the treatment regimens (selection of acupoints and methods of needling manipulation, needle retention time). Randomly, half of the patients will receive treatments from acupuncturist 1 in the first treatment cycle and from acupuncturist 2 in the second cycle; while the other half will be treated in other way round. There is a washout period (21 days) between two cycles. The needling manipulation of two acupuncturists will be measured objectively during treatments. The clinical effect will be measured by the control of vomiting and nausea during and after chemotherapy treatments.

Detailed description

This is a randomized, controlled cross-over trial. The hypothesis of this study is that the differences in manual acupuncture manipulation can impact clinical effect though the acupuncturists follow the same needling regimen. In this study, acupuncturist 1 (clinical experience \>15 years) and acupuncturist 2 (\<5 years) will give treatments to cancer patients receiving cisplatin chemotherapy (n=36) for at least two continuous cycles, once per day, 5 days per cycle. Acupuncturist 1 determines all the treatment regimens (selection of acupoints and methods of needling manipulation, needle retention time). Randomly, half of the patients will receive treatments from acupuncturist 1 in the first treatment cycle and from acupuncturist 2 in the second cycle; while the other half will be treated in other way round. There is a washout period (21 days) between two cycles. The needling manipulation of two acupuncturists will be measured objectively during treatments. The clinical effect will be measured by the control of vomiting and nausea during and after chemotherapy treatments. The manual manipulation of two acupuncturists will be recorded by device Acusensor.

Interventions

PROCEDUREManual acupuncture implemented by acupuncturist 1

Manual acupuncture once per day. Acupuncture treatment regimens (acupoints, needling methods, needle retention time) were decided by acupuncturist 1 according to the syndrome differentiation of patients. Acupuncturist 1 has to have more than 15 years of acupuncture clinical practice experience.

PROCEDUREManual acupuncture implemented by acupuncturist 2

Manual acupuncture given by acupuncturist 2 once per day. Acupuncture treatment regimens (acupoints, needling methods, needle retention time) were decided by acupuncturist 1 according to the syndrome differentiation of patients. Acupuncturist 2 has to have less than 5 years of acupuncture clinical practice experience.

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
CollaboratorOTHER
Beijing University of Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of cancer * Must receive cancer chemotherapy containing cisplatin * Able to complete at least two continuous chemotherapy treatment cycles * Karnofsky performance status grade ≥60 * Must use 5-TH receptor antagonists as an antiemetic drug in the chemotherapy duration

Exclusion criteria

* Concurrent neoplasms or illness that induces nausea independent of chemotherapy * Receiving radiotherapy * Received acupuncture treatments for other conditions less than 4 weeks before chemotherapy treatment * Severe infection * Severe heart, liver, kidney and brain diseases * Unconsciousness * Psychosis * Language barriers * Cardiac pacemaker * Radiotherapy or hormone therapy during chemotherapy treatments

Design outcomes

Primary

MeasureTime frame
NCI nausea and vomiting rating scaleday1-8 on each study period

Secondary

MeasureTime frame
global assessment on effectiveness by patients (VAS)day 5 on each study period
Rhodes Scaleday1-5 on each study period
patients' confidence towards acupuncture treatment(VAS)day 1,5 on each study period
global satisfaction for acupuncture treatmentsday 5 on each study period
Acupuncture Expectancy Scale (AES)day 1, 3, 5 on each study period

Other

MeasureTime frameDescription
Adverse events (not acupuncture treatment specified)day 1-5 each study period
Needling manipulation parametersday 1-5 each study periodDisplacement Frequency (Hz) Displacement Amplitude (pk-pk) Rotation Frequency (Hz) Rotation Amplitude (pk-pk)
Acupuncture related adverse eventsday 1-5 each study periodfaintng during acupuncture treatment, sticking of needle, bleeding in the needling hole, broken needles
patient communication satisfaction scaleday 5 on each study period

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026